The voting question for today’s FDA VRBPAC Meeting on the Covid Vaccine strain for this fall is:
“For the 2024-2025 Formula of COVID-19 vaccines in the U.S., does the
committee recommend a monovalent JN.1-lineage vaccine composition?
Please vote “Yes” or “No” or “Abstain.”
The FDA Selection of the 2024-2025 Formula for COVID-19 vaccines briefing document has a thorough review on the issue.
Go Retire Psychiatrist 